Tuberculosis: The elephant in the AIDS clinic?

AIDS

Volumn 20, Issue 9, 2006, Pages 1323-1325

  Marston, Barbara ^a,b   Miller, Bess ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; THORAX RADIOGRAPHY; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMBULATORY CARE FACILITIES; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; INTERNATIONAL COOPERATION; MYCOBACTERIUM TUBERCULOSIS; RISK; TUBERCULOSIS;

EID: 33745836749     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000232241.13168.5c     Document Type: Short Survey

References (23)

1. Bonnet M, Pinoges L, Varaine F, Oberhauser B, O'Brien D, Kebede Y, et al. Tuberculosis after HAART initiation in HIV patients from five MSF programs held in high TB burden countries. AIDS 2006; 20:1275-1279.
2. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40:1500-1507.
3. http://www.stoptb.org/wg/new_diagnostics/assets/documents/ expert_consultation_sep05.pdf [Accessed 24 January 2006]
4. http://www.who.int/tb/smear_neg_tb_callforcomments/en/. [Accessed 2 January 2006]
5. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353:2325-2334.
6. Spacek L, Shihab H, Kamya M, Mwesigire D, Ronald A, Mayanja H, et al. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis 2006; 42:252-259.
7. External Quality Assessment for AFB Smear Microscopy, World Health Organization, International Union Against Tuberculosis and Lung Disease, CDC, The Royal Dutch Tuberculosis Society, Research Institute of Tuberculosis Japan. Washington DC: APHL; Sept 2002. http://www.aphl.org/programs/ infectious_diseases/eqa.cfm.
8. Breen R, Smith C, Cropley I, Johnson M, Lipman M. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005; 19:1201.
9. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5:361-373.
10. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9:A11-A15.
11. Bock N, Reichman LB. Tuberculosis and HIV/AIDS: epidemiological and clinical aspects (world perspective). Semin Respir Crit Care Med 2004; 25:337-344.
12. Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med 2005; 172:123-127.
13. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999; 74(46)385-398.
14. Mosimaneotsile B, Nyirenda S, Talbot E, Motsamai O, Kilmarx PH, Wells CD. Characteristics of people living with HIV-1 screened for isoniazid preventive therapy, Botswana, 2005. Int J Tuberc Lung Dis 2005; 9:198.
15. Jones JL, Hanson DL, Dworkin MS, De Cock KM, The Adult/Adolescent Spectrum of HIV Disease Group. HIV associated TB in the era of HAART. Int J Tuberc Lung Dis 2000; 4:1026-1031.
16. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359:2059-2064.
17. Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 2002; 34:543-546.
18. Corbett EL, Marston B, Churchyard GJ, DeCock KM. Tuberculosis in Sub-Saharan Africa: opportunities, challenges and change in the era of antiretroviral therapy. Lancet 2006; in press.
19. World Health Organization. Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings. Geneva: WHO; 1999. WHO/CDS/TB/99.269.
20. Perkins MD, Small P. Admitting defeat. Int J Tuberc Lung Dis 2006; 10:1.
21. http://www.news24.com/News24/South_Africa/Aids_Focus/0,6119, 2-7-659_1557958,00.html. [Accessed 31 August 2004]
22. http://www.state.gov/documents/organization/29831.pdf [Accessed 24 January 2006]
23. WHO/HTM/TB/2004.330 2004 (http://www.who.int/hiv/pub/tb/tbhiv/en/) [Accessed 24 January 2006]